Ziwei Huang Selected Research

mHA11

8/2019	Pharmacokinetics of a novel microtubule inhibitor mHA11 in rats.
8/2013	Development of a novel class of tubulin inhibitors with promising anticancer activities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ziwei Huang Research Topics

Disease

23	Neoplasms (Cancer) 07/2022 - 01/2002
10	Infections 07/2022 - 08/2002
8	Muscular Atrophy (Muscle Atrophy) 01/2021 - 01/2019
8	Inflammation (Inflammations) 12/2020 - 08/2002
7	Atrophy 01/2021 - 01/2019
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2020
5	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2002
4	Pathologic Processes 02/2013 - 01/2006
3	Neoplasm Metastasis (Metastasis) 03/2022 - 01/2017
2	Renal Cell Carcinoma (Grawitz Tumor) 07/2022 - 01/2020
2	COVID-19 01/2022 - 04/2021
2	Hyperuricemia 12/2021 - 01/2021
2	Colitis 04/2021 - 01/2021
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2006 - 05/2002
1	Hyperglycemia 07/2022
1	Dyslipidemias (Dyslipidemia) 07/2022
1	Hypoglycemia (Reactive Hypoglycemia) 07/2022
1	Insulin Resistance 07/2022
1	Stroke (Strokes) 06/2022
1	Gout 12/2021
1	Ovarian Neoplasms (Ovarian Cancer) 10/2021
1	Ulcerative Colitis 04/2021
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 04/2021
1	Virus Diseases (Viral Diseases) 04/2021
1	Hematologic Neoplasms (Hematological Malignancy) 04/2021
1	Adenocarcinoma of Lung 03/2021
1	Disease Progression 01/2021
1	Hemoptysis 01/2021
1	Osteoarthritis 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2020

Drug/Important Bio-Agent (IBA)

9	LigandsIBA 03/2021 - 08/2002
7	Immune Checkpoint InhibitorsIBA 10/2021 - 01/2020
5	Proteins (Proteins, Gene)FDA Link 03/2022 - 02/2013
5	Chemokine ReceptorsIBA 03/2022 - 08/2002
5	Peptides (Polypeptides)IBA 06/2013 - 01/2006
4	ChemokinesIBA 12/2020 - 01/2006
3	BerberineIBA 07/2022 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2020
3	Biological ProductsIBA 04/2021 - 01/2011
3	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2021 - 09/2019
3	Programmed Cell Death 1 ReceptorIBA 03/2021 - 01/2020
2	Antiviral Agents (Antivirals)IBA 03/2022 - 04/2021
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2021 - 01/2021
2	Dextran SulfateIBA 04/2021 - 01/2021
2	coptisineIBA 04/2021 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 12/2020
2	Small Interfering RNA (siRNA)IBA 01/2021 - 12/2020
2	CytokinesIBA 12/2020 - 01/2019
2	Beclin-1IBA 12/2020 - 11/2019
2	Myosin Heavy Chains (Myosin Heavy Chain)IBA 11/2020 - 01/2020
2	CalciumIBA 08/2020 - 06/2013
2	isoquercitrinIBA 01/2020 - 11/2019
2	UbiquitinIBA 01/2020 - 09/2019
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2020
2	B7-H1 AntigenIBA 01/2020 - 01/2020
2	Long Noncoding RNAIBA 01/2020 - 10/2019
2	MicroRNAs (MicroRNA)IBA 10/2019 - 09/2019
2	mHA11IBA 08/2019 - 08/2013
2	Renilla LuciferasesIBA 01/2017 - 01/2017
2	Arginine (L-Arginine)FDA Link 01/2015 - 01/2006
2	Ephrin-B2 (Ephrin B2)IBA 02/2013 - 01/2011
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2013 - 01/2011
2	CateninsIBA 04/2012 - 01/2012
1	Adenosine Triphosphate (ATP)IBA 07/2022
1	LipidsIBA 07/2022
1	Uncoupling Protein 1IBA 07/2022
1	Glucose (Dextrose)FDA LinkGeneric 07/2022
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 07/2022
1	AMP-Activated Protein KinasesIBA 07/2022
1	daclatasvirIBA 07/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 07/2022
1	chrysomycin AIBA 04/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 03/2022
1	osimertinibIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Uric Acid (Urate)IBA 12/2021
1	HypoxanthineIBA 12/2021
1	berberrubineIBA 12/2021
1	potassium oxonateIBA 12/2021
1	Antineoplastic Agents (Antineoplastics)IBA 04/2021
1	isoquinolineIBA 01/2021
1	CrizotinibIBA 01/2021
1	IntegrinsIBA 01/2021
1	Drug CombinationsIBA 01/2021
1	InterferonsIBA 01/2021
1	InflammasomesIBA 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021
1	AlkaloidsIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	EnzymesIBA 12/2020

Therapy/Procedure

12	Therapeutics 06/2022 - 04/2012
7	Denervation 12/2020 - 01/2019
2	Immunotherapy 01/2022 - 01/2020
1	Neurological Rehabilitation 06/2022
1	Precision Medicine 06/2022
1	Hematopoietic Stem Cell Mobilization 03/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021